A Novel Tocolytic Agent: Effects of Letrozole on Gestational Length and Parturition Time

 

 Buy Article Permissions and Reprints

ABSTRACT

The purpose of this study was to determine whether letrozole, a potent aromatase inhibitor, could prolong gestation and/or delay parturition in rats. Seventy-five rats were divided into five groups of 15 rats each. Group I and group II rats were administered letrozole orally at doses of 0.002 and 0.02 mg/kg/day from days 15 through 21 of pregnancy, respectively. Rats in group IA were administered a concomitant estradiol cyclopentylpropionate (ECP) injection on day 15 and 0.002 mg/kg letrozole in that same manner as for group I. Rats in group IIA were administered concomitant ECP on day 15 and 0.02 mg/kg letrozole in the same manner as for group II. The control group received sterile saline only. Study and control groups were compared with respect to gestational length, parturition time, fetal mortality rate, stillbirth rate, and fetal body weight. Oral administration of letrozole both at daily doses of 0.002 mg/kg/day (group I) and 0.02 mg/kg/day (group II) consistently prolonged gestation and parturition time. The values of stillbirth rate, fetal mortality rate, and fetal body weight of group I were similar to those in the control group; conversely, fetal mortality rate and stillbirth rate of group II were higher than those values in the control group, and fetal body weight of group II was lower than in the control group. It was observed that concomitant injection of ECP effectively reversed the deleterious effects of letrozole on gestational length, parturition time, fetal mortality rate, stillbirth rate, and fetal body weight. The results of this study indicate that the aromatase inhibitor letrozole can prolong gestation and delays parturition in rats. Its deleterious effects on parturition can be reversed by ECP injection.

REFERENCES

• 1 Bernal A L. Overview of current research in parturition.  Exp Physiol. 2001;  86 213-222
  CrossrefPubMedGoogle Scholar
• 2 Riley S C, Leask R, Selkirk J V et al.. Increase in 15-hydroxyprostaglandin dehydrogenase activity in the ovine placentome at parturition and effect of oestrogen.  J Reprod Fertil. 2000;  119 329-338
  PubMedGoogle Scholar
• 3 Challis J R, Matthews S G, Gibb W, Lye S J. Endocrine and paracrine regulation of birth at term and preterm.  Endocr Rev. 2000;  21 514-550
  CrossrefPubMedGoogle Scholar
• 4 Chatterjee A, Singh R, Chatterjee R. Dexamethasone modulation of gestation length and parturition in rats.  Pharmacol Res. 1993;  27 359-364
  CrossrefPubMedGoogle Scholar
• 5 Mesiano S. Myometrial progesterone responsiveness and the control of human parturition.  J Soc Gynecol Investig. 2004;  11 193-202
  CrossrefPubMedGoogle Scholar
• 6 Wu W X, Ma X H, Coksaygan T et al.. Prostaglandin mediates premature delivery in pregnant sheep induced by estradiol at 121 days of gestational age.  Endocrinology. 2004;  145 1444-1452
  CrossrefPubMedGoogle Scholar
• 7 Fang X, Wong S, Mitchell B F. Relationships among sex steroids, oxytocin, and their receptors in the rat uterus during late gestation and at parturition.  Endocrinology. 1996;  137 3213-3219
  CrossrefPubMedGoogle Scholar
• 8 Di W L, Lachelin G C, McGarrigle H H, Thomas N S, Becker D L. Oestriol and oestradiol increase cell to cell communication and connexin43 protein expression in human myometrium.  Mol Hum Reprod. 2001;  7 671-679
  CrossrefPubMedGoogle Scholar
• 9 Cohen M H, Johnson J R, Li N, Chen G, Pazdur R. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer.  Clin Cancer Res. 2002;  8 665-669
  PubMedGoogle Scholar
• 10 Lumbers E R. Effects of drugs on uteroplacental blood flow and the health of the foetus.  Clin Exp Pharmacol Physiol. 1997;  24 864-868
  PubMedGoogle Scholar

Hasan KafaliM.D. 

Department of Obstetrics and Gynecology

Fatih University, Ankara, Turkey